<DOC>
	<DOC>NCT00583401</DOC>
	<brief_summary>Closure of Patent Foramen Ovale with the AMPLATZERÂ® PFO OCCLUDER in patients with at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional therapy.</brief_summary>
	<brief_title>PFO ACCESS Registry</brief_title>
	<detailed_description>The primary objective of the PFO Access Registry is to allow access to the AMPLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional drug therapy.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Foramen Ovale, Patent</mesh_term>
	<criteria>Patent foramen ovale(PFO) recurrent stroke failed antiplatelet/anticoagulant therapy International normalized ration (INR) outside of 23 intracardiac thrombus (subjects may be enrolled after resolution of thrombus)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>PFO</keyword>
	<keyword>stroke</keyword>
</DOC>